Wolverine Trading
MRNS

Wolverine Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Wolverine Trading’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,165
Closed -$101K – 5398
2024
Q1 		$101K Buy
+11,165
New +$109K ﹤0.01% 4051
2023
Q4 		– Sell
-13,202
Closed -$98.9K – 5410
2023
Q3 		$106K Buy
+13,202
New +$110K ﹤0.01% 3982
2023
Q2 		– Sell
-10,263
Closed -$72K – 5155
2023
Q1 		$72K Buy
+10,263
New +$64.4K ﹤0.01% 3747
2021
Q3 		– Sell
-10,181
Closed -$140K – 7170
2021
Q2 		$185K Sell
10,181
-8,033
-44% -$129K ﹤0.01% 5067
2021
Q1 		$261K Buy
+18,214
New +$263K ﹤0.01% 4653
2020
Q3 		– Sell
-4,248
Closed -$36.7K – 5313
2020
Q2 		$43K Sell
4,248
-2,937
-41% -$27K ﹤0.01% 4336
2020
Q1 		$53K Buy
7,185
+1,003
+16% +$8.69K ﹤0.01% 4242
2019
Q4 		$54K Buy
+6,182
New +$34.7K ﹤0.01% 4448
2019
Q3 		– Sell
-5,018
Closed -$40.5K – 5187
2019
Q2 		$83K Sell
5,018
-2,336
-32% -$40.6K ﹤0.01% 4078
2019
Q1 		$123K Buy
7,354
+4,356
+145% +$62.7K ﹤0.01% 4061
2018
Q4 		$36K Buy
+2,998
New +$60.7K ﹤0.01% 4219

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wolverine Trading's MRNS Position: Q2 2024 in Review

Wolverine Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 11,165 shares — an estimated $101K sold.

Wolverine Trading first reported a position in MRNS in Q4 2018 and held it in 11 quarters. The position peaked at $261K in Q1 2021. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Wolverine Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Wolverine Trading sold 11,165 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $101K.
  • Wolverine Trading first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 11 quarters.
  • Wolverine Trading's Marinus Pharmaceuticals, Inc position peaked at $261K in Q1 2021.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Wolverine Trading's 13F filing for Q2 2024, filed 14 Aug 2024.